Sort by:
Hwang WL, Niemierko A, Hwang KL, Hubbeling H, Schapira E, Gainor JF, Keane FK
Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy.
JAMA Oncol. 2018;4(2):253-255 - PMID: 28973343 - PMCID: PMC5838581 - DOI: 10.1001/jamaoncol.2017.3808
Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
JAMA Oncol. 2018;4(5):e175230 - PMID: 29372236 - PMCID: PMC5885162 - DOI: 10.1001/jamaoncol.2017.5230
Hwang WL, Niemierko A, Efstathiou JA
Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy-Reply.
JAMA Oncol. 2018;4(11):1620-1621 - PMID: 30422248 - DOI: 10.1001/jamaoncol.2018.3552
Hwang WL, Pleskow HM, Miyamoto DT
Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
Adv Drug Deliv Rev. 2018;125:122-131 - PMID: 29326053 - DOI: 10.1016/j.addr.2018.01.003
Sanford NN, Mahal BA, Royce TJ, Pike LRG, Hwang WL
Sex Disparity and Copy Number Alterations in Esophageal Squamous Cell Carcinoma.
Clin Gastroenterol Hepatol. 2018;17(6):1207-1209 - PMID: 30120994 - DOI: 10.1016/j.cgh.2018.08.026
Pike LRG, Hwang WL, Royce TJ, Sanford NN, Mahal BA
HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynx.
Oral Oncol. 2018;86:69-74 - PMID: 30409322 - DOI: 10.1016/j.oraloncology.2018.09.007
Hwang WL, Pike LRG, Royce TJ, Mahal BA, Loeffler JS
Safety of combining radiotherapy with immune-checkpoint inhibition.
Nat Rev Clin Oncol. 2018;15(8):477-494 - PMID: 29872177 - DOI: 10.1038/s41571-018-0046-7
7 CSV